MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    A new aroma in the new world

    H. Fajardo, A. Medina, P. Gomez, r. Medina (tegucigalpa, Honduras)

    Objective: Investigate if olfactory impairment in PD patients  are related with other non motor symptoms Background: Non motor symptoms (NMS) can precede Parkinson's Disease (PD)…
  • 2017 International Congress

    Sleep quality in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel infusion

    O. De Fabregues, A. Ferré, O. Romero, J. Dot, M. Abu-Suboh, M. Quintana, J.R. Armengol, J. Alvarez-Sabin (Barcelona, Spain)

    Objective: To describe the effects of levodopa/carbidopa intestinal gel (LCIG) infusion on sleep quality in patients with advanced Parkinson's disease (PD).  Background: Worsening of sleep…
  • 2017 International Congress

    The impact of divided attention in dual task conditions on drooling in Parkinson’s Disease (PD): a pilot study

    H. Reynolds, N. Miller, R. Walker (Gateshead, United Kingdom)

    Objective: To investigate whether frequency of saliva swallows reduced, and drooling severity and frequency increased, when people with PD engaged in a distracting cognitively demanding…
  • 2017 International Congress

    Deep Brain Stimulation and Olfactory Function in Parkinson’s Disease

    O. Saatci, B. Polat, N. Helvaci Yilmaz, T. Zirh (Istanbul, Turkey)

    Objective: To evaluate the olfactory functions in the preoperative and postoperative period in Parkinson's Disease (PD) patients who underwent deep brain stimulation (DBS) of bilateral subthalamic nucleus (STN)…
  • 2017 International Congress

    Probiotic correction of intestinal dysbiosis in Parkinson’s disease

    I. Miliukhina, E. Ermolenko, A. Ivanova, M. Kotyleva, A. Suvorov (Saint-Petersburg, Russian Federation)

    Objective: To reveal the effect of probiotic on the content and condition of intestinal microbiota in Parkinson's disease (PD). Background: Constipation is an important non-motor…
  • 2017 International Congress

    Parkinson’s Disease from the Patient Perspective

    L. Mischley, G. Canada, R. Lau (Kenmore, WA, USA)

    Objective: The purpose of this study was to describe the constellation of parkinsonian symptoms, as experienced by the patient. Background: For 200 years, the cardinal…
  • 2017 International Congress

    Gender differences in motor and non-motor features across the Parkinson’s disease spectrum

    T. Dunne, G. Stebbins, C. Goetz, S. Luo, J. Goldman (Chicago, IL, USA)

    Objective: To examine how gender differences influence the motor and non-motor features across the Parkinson’s disease (PD) spectrum. Background: There is evidence of male predominance…
  • 2017 International Congress

    Pain and Parkinson’s disease

    H. Wilson, T. Yousaf, G. Pagano, M. Politis (London, United Kingdom)

    Objective: We aimed to explore clinical correlates and risk factors in the development of pain, alongside the relationship between pain and striatal dopaminergic dysfunction in…
  • 2017 International Congress

    Sleepiness and depression in Korean patients with Parkinson’s disease treated with ropinirole and levodopa

    S.Y. Kang, H.-S. Ryu, M.-K. Sunwoo, S.-J. Kim, J.-S. Baik, M.-Y. Park, H.-E. Park, J.-S. Kim, K.-Y. Kwon, S.-B. Koh, Y.-E. Kim, M.-K. Lee, J.-M. Kim, S.J. Chung, Y.-H. Sohn (Hwaseong, Republic of Korea)

    Objective: We aimed to investigate the effect of ropinirole on excessive daytime sleepiness (EDS) and depression in Parkinson’s disease (PD) with large population. Background: EDS…
  • 2017 International Congress

    Long-term levodopa therapy accelerates the circadian rhythm dysfunction in 6-OHDA rat model

    D. Lv, Y. Wang, F. Wang, X. Zhang, X. Gu, Y. Yang (Suzhou, China)

    Objective: We aimed to study the effect of L-DOPA on circadian rhythms in 6-OHDA lesioned rats, and to clarify whether the disturbance of the circadian…
  • « Previous Page
  • 1
  • …
  • 1204
  • 1205
  • 1206
  • 1207
  • 1208
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Life expectancy with and without Parkinson’s disease in the general population
    • The hardest symptoms that bother patients with Parkinson's disease
    • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley